Table 3 Antibiotic sensitivity of the multi-drug resistant gram negative isolates
Organisms | Pip/Taz | Imepenem | Polymyxin B | Gentamycin | Amikacin | Aztreonam | Ceftriaxone | Ceftazidime | Ofloxacin | Cefuroxime | Amp/clav | Tobramycin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acinetobacter Species | 0/12 | 0/12 | 12/12 | 0/12 | 0/12 | 0/6 | 0/12 | 0/12 | 0/12 | 0/8 | 0/2 | 6/9 |
(0%) | (0%) | (100%) | (0%) | (0%) | (0%) | (0%) | (0%) | (0%) | (0%) | (0%) | (66.6%) | |
Klebsiella Pneumoniae | 5/8 | 6/8 | 3/3 | 0/8 | 3/8 | 0/8 | 0/8 | 0/2 | 2/8 | 0/7 | 2/7 | Â |
(62.5%) | (75%) | (100%) | (0%) | (37.5%) | (0%) | (0%) | (0%) | (25%) | (0%) | (28.6%) | Â | |
Pseudomonas Aeruginosa | 3/5 | 1/6 | 5/5 | 1/6 | 2/6 | ¼ | 0/3 | 2/4 | 1/6 | 0/2 | -- | 0/1 |
(60%) | (16.7%) | (100%) | (16.7%) | (33.3%) | (25%) | (0%) | (50%) | (16.7%) | (0%) | Â | (0%) | |
Escherichia Coli | 5/7 | 7/7 | -- | 5/7 | 7/7 | 0/7 | 0/7 | 0/1 | 4/7 | 0/6 | 3/7 | -- |
(71.5%) | (100%) | Â | (71.5%) | (100%) | (0%) | (0%) | (0%) | (57.2%) | (0%) | (42.8%) | Â | |
Enterobacter Species | ¾ | 4/4 | -- | 1/5 | 1/5 | 0/4 | 0/4 | 0/1 | ¼ | 0/4 | ¼ | -- |
(75%) | (100%) | Â | (20%) | (20%) | (0%) | (0%) | (0%) | (25%) | (0%) | (25%) | Â | |
Stenotrophomonas Maltophilia | ½ | -- | -- | 0/1 | 0/1 | 0/2 | 0/2 | ½ | ¾ | -- | -- | -- |
(50%) | Â | Â | (0%) | (0%) | (0%) | (0%) | (50%) | (75%) | Â | Â | Â | |
Burkholderia Cepacia | -- | ½ | -- | -- | -- | -- | -- | 2/2 | 2/2 | -- | -- | -- |
| Â | (50%) | Â | Â | Â | Â | Â | (100%) | (100%) | Â | Â | Â | |
Pseudomonas Species | ½ | 2/3 | 3/3 | 1/3 | 1/3 | 0/3 | 0/3 | 0/1 | 1/3 | 0/1 | -- | 0/1 |
(50%) | (66.6%) | (100%) | (33.3%) | (33.3%) | (0%) | (0%) | (0%) | (33.3%) | (0%) | Â | (0%) | |
n (%) | 18/40 | 21/42 | 23/23 | 8/42 | 14/42 | 1/34 | 0/39 | 5/25 | 14/46 | 0/28 | 6/20 | 6/11 |
(45%) | (50%) | (100%) | (19.1%) | (35.8%) | (3%) | (0%) | (40%) | (30.5%) | (0%) | (30%) | (54.6%) |